Basepaws offers at-home genetic testing for cats and dogs using DNA analysis to provide detailed insights into breed composition, health markers, and dental health risks. This service enables pet owners to proactively manage their pets' health by identifying genetic predispositions and informing care decisions.

Mirna develops precision veterinary diagnostics technology that enhances disease testing for companion animals, improving the accuracy and speed of diagnoses. Their NEMO Companion Animal Test addresses the need for better diagnostic tools in veterinary practices, ultimately leading to improved patient outcomes and client engagement.

Web applications increasingly face automated attacks, credential stuffing, and fraudulent traffic that bypass traditional security controls, leading to data breaches, revenue loss, and degraded user experience. Distinguishing legitimate users from bots or compromised browsers in real time is difficult without intrusive challenges that can deter customers. Existing solutions often rely on static blacklists or CAPTCHAs, which are insufficient against sophisticated evasion techniques.

This company develops evidence-based longevity medicines specifically for cats by addressing the molecular mechanisms of aging. Utilizing computational modeling and machine learning, they design therapeutics aimed at delaying disease onset and extending healthy lifespan. Their goal is to improve the quality of life for senior cats by treating the biology of aging itself.

VETmAb BIO develops monoclonal antibodies specifically designed for treating debilitating diseases in dogs and cats, utilizing human-validated targets to reduce technical risk in veterinary medicine. The company addresses the lack of effective biopharmaceutical treatments in the veterinary field by leveraging proprietary technologies to create targeted therapies for unmet medical needs in pets.